Marina Asher

999 total citations
10 papers, 560 citations indexed

About

Marina Asher is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Marina Asher has authored 10 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Marina Asher's work include Sarcoma Diagnosis and Treatment (2 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Protein Degradation and Inhibitors (2 papers). Marina Asher is often cited by papers focused on Sarcoma Diagnosis and Treatment (2 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Protein Degradation and Inhibitors (2 papers). Marina Asher collaborates with scholars based in United States, Australia and Germany. Marina Asher's co-authors include Irina Linkov, Amanda Hummer, Robert A. Soslow, Michelle Reid‐Nicholson, P. Iyengar, Howard T. Thaler, Rohit Bhargava, Farbod Darvishian, Elisa de Stanchina and Natasha Rekhtman and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Cell Reports.

In The Last Decade

Marina Asher

9 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marina Asher United States 8 212 201 199 157 144 10 560
Pooja Patel United States 7 121 0.6× 198 1.0× 85 0.4× 56 0.4× 48 0.3× 14 482
Rebecca J. Wolsky United States 8 223 1.1× 88 0.4× 275 1.4× 216 1.4× 89 0.6× 21 624
Violeta R. McGaughy United States 7 129 0.6× 103 0.5× 70 0.4× 59 0.4× 33 0.2× 8 450
P. Iyengar Canada 12 150 0.7× 109 0.5× 154 0.8× 130 0.8× 70 0.5× 24 517
Robert Orlowski United States 11 107 0.5× 94 0.5× 279 1.4× 215 1.4× 75 0.5× 35 673
Danuta Skomra Poland 12 112 0.5× 71 0.4× 69 0.3× 36 0.2× 36 0.3× 45 344
Congwei Jia China 13 202 1.0× 30 0.1× 59 0.3× 138 0.9× 134 0.9× 63 564
Elizabeth Kornaga Canada 11 152 0.7× 68 0.3× 95 0.5× 35 0.2× 88 0.6× 24 437
H. Tsuda Japan 9 343 1.6× 55 0.3× 83 0.4× 54 0.3× 103 0.7× 15 554
Malti Kshirsagar United States 9 201 0.9× 151 0.8× 90 0.5× 125 0.8× 176 1.2× 9 603

Countries citing papers authored by Marina Asher

Since Specialization
Citations

This map shows the geographic impact of Marina Asher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Asher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Asher more than expected).

Fields of papers citing papers by Marina Asher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Asher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Asher. The network helps show where Marina Asher may publish in the future.

Co-authorship network of co-authors of Marina Asher

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Asher. A scholar is included among the top collaborators of Marina Asher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Asher. Marina Asher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Odintsov, Igor, Marissa S. Mattar, Michael Offin, et al.. (2021). Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers. Journal of Thoracic Oncology. 16(7). 1149–1165. 21 indexed citations
2.
Caeser, Rebecca, Emily A. Costa, Vidushi Durani, et al.. (2021). MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer. iScience. 24(11). 103224–103224. 20 indexed citations
3.
Ogura, Koichi, Romel Somwar, Julija Hmeljak, et al.. (2020). Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor. Clinical Cancer Research. 27(4). 1184–1194. 24 indexed citations
4.
Wohlhieter, Corrin A., Allison L. Richards, Fathema Uddin, et al.. (2020). Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer. Cell Reports. 33(9). 108444–108444. 158 indexed citations
5.
Spraggon, Lee, Julija Hmeljak, Heather Magnan, et al.. (2018). Abstract B12: Therapeutic potential of NTRK3 in desmoplastic small round cell tumor. Clinical Cancer Research. 24(2_Supplement). B12–B12. 1 indexed citations
6.
Griewank, Klaus, Johannes van de Nes, Bastian Schilling, et al.. (2013). Genetic and clinico-pathologic analysis of metastatic uveal melanoma. Modern Pathology. 27(2). 175–183. 68 indexed citations
7.
Fury, Matthew G., Marija Drobnjak, Camelia S. Sima, et al.. (2010). Tissue microarray evidence of association between p16 and phosphorylated eIF4E in tonsillar squamous cell carcinoma. Head & Neck. 33(9). 1340–1345. 13 indexed citations
8.
Kalinsky, Kevin, Lindsay M. Jacks, Cyrus V. Hedvat, et al.. (2009). Use of multiplex mutation genotyping to identify novel and protective mutations in breast cancer. Journal of Clinical Oncology. 27(15_suppl). 11004–11004.
9.
Reid‐Nicholson, Michelle, P. Iyengar, Amanda Hummer, et al.. (2006). Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. Modern Pathology. 19(8). 1091–1100. 151 indexed citations
10.
Darvishian, Farbod, Amanda Hummer, Howard T. Thaler, et al.. (2004). Serous Endometrial Cancers That Mimic Endometrioid Adenocarcinomas. The American Journal of Surgical Pathology. 28(12). 1568–1578. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026